Study Targeting Myocardial Perfusion and Symptom Relief in Women With SGLT2 Inhibitors (STRONG)

NCT06600178 · clinicaltrials.gov ↗

PHASE1

Phase

RECRUITING

Status

150

Enrollment

OTHER

Sponsor class

Conditions

Angina Patients With Non-obstructive Coronary Artery Disease
Coronary Microvascular Disease
Coronary Microvascular Dysfunction (CMD)

Interventions

DRUG: Brezavvy 20Mg Oral Tablet
DRUG: Placebo

Sponsor

University of Virginia